Curis, Inc. (NASDAQ:CRIS) Could Reverse On Near Term Catalysts
Massachusetts based biotech Curis, Inc. (NASDAQ:CRIS) soared into the close of 2015, as data from its lead oncology candidate hinted at a revolution in cancer therapy. The company has had a rough to-date 2016, however, and currently trades